The National Administration of Medicines, Food and Medical Technology (Anmat) communicated the prohibition of 10 medicines through provision 2300/2022 of the Official Gazette. The reason would be that these gels and creams for medicinal use did not have the necessary authorization to be marketed and can be risky for health.
After this statement, the list of the ten products that will be removed from the shelves starting this Wednesday was published because they are considered risky for consumers. Among the drugs that were banned by Anmat are products from the Rasmusen, Iris SA, Megapar and Villa Luján laboratories.
Communicate with @ANMATsalud:
▪️ By phone at 0800-333-1234 from Monday to Friday from 8 a.m. to 8 p.m. and Saturdays, Sundays and holidays from 10 a.m. to 6 p.m.
▪️ Via email to [email protected]
▪️ Or by completing the web form at https://t.co/ooUhZaCwsA pic.twitter.com/vlZ3MoeoAf
– ANMAT (@ANMATsalud) February 22, 2022
In order to analyze these products, samples were seized to inspect if they are hazardous to health. The drugs that were banned are:
-Triple action shark cartilage regenerating gel (Villa Luján Laboratory).
– Cremagel Sanfirol (Rasmusen Laboratory).
-Original Kalma Ya.
– Mentisan menthol cream.
– Cannabis cream for pain (Megapar Laboratory)
– Direct pain gel Ultra Kemgué Concentrate (Rasmusen Laboratory)
– New Maximized Atom3 formula (Iris SA Laboratory)
The product investigation began with a consumer complaint via email about a specific product. From there, Anmat registered that both this product and the others did not have authorization to be marketed.
Given this, they were considered as risky for the health of consumers since there is no evidence that these products are safe for use. By prohibiting marketing at the national level, the safety of consumers regarding these gels and creams can be guaranteed.
As for the signatures of these products, the Anmat Technical Information Management Directorate assured that there are no records in the fields of medicines, medical products or cosmetic products of these laboratories.
According to the Ministry of Health of the province of Buenos Aires, the Iris SA laboratory is not enabled. On the other hand, the Ministry of Health of La Pampa declared that no physical establishments of the Rasmusen and Villa Luján laboratories were found. Lastly, the Chubut Ministry of Health reported that there is no laboratory that makes medicines called Megapar.